Scholars Central

Conference abstract

Production and optimization of dengue virus- like particles for immunization

Authors: G Singh, V N Chouljenko, K G Kousoulas, A J Ramsay

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dengue virus (DENV) causes more than 100 million cases of dengue fever (DF) annually, making it the common and widespread viral infection of the humans and there are no protective vaccines available currently. Moreover, individuals exposed to DENV infections earlier appear to be more susceptible to complications after secondary infection, a phenomenon attributed to antibodydependent enhancement (ADE). DENV serotypes can be readily produced in cell culture through the expression of the heterologous pre-membrane/membrane (prM/M) and envelope (E) structural proteins that contain the majority of immunogenic domains for antibodies against DENV, have recently gained considerable attention for studies of viral replication and as potential vaccine target. Baculovirus expression systems in insect cells have emerged as a highly efficient means of producing sub-unit vaccines that generate potent protective immune responses against a variety of viral pathogens. We made DENV-2 VLPs through heterologous expression of the full prM/M and E structural proteins in insect cell cultures such as Sf9 and high five cells. The prM/M and E genes were successfully synthesized as codon-optimized gene cassettes in recombinant baculoviruses, expressing combinations of DENV-2 prM/M and E proteins that packaged a DENV-2 replicon with a single poly prM/M-E gene and produced single-round VLP in culture. After recovery of recombinant VLP from cells, expression of DENV-2 proteins was checked by western blotting and later confirmed for VLP production through transmission electron microscopy. Studies are underway to test the efficacy and immunogenicity of these DNA constructs under the appropriate animal models. Vaccine antigens generated through this robust system may serve as a candidate DENV vaccines.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Microbiology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Microbiology: Open Access
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “G Singh”
  • BylineArticles whose byline prints “V N Chouljenko”
  • BylineArticles whose byline prints “K G Kousoulas”
  • BylineArticles whose byline prints “A J Ramsay”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels